非酒精性脂肪肝(Nonalcoholic Fatty Liver Disease,NAFLD)是指酒精和其它明确的损肝因素之外所致的肝细胞内脂肪过度沉积引发的代谢应激性肝脏损伤。非酒精性脂肪性肝炎(Nonalcoholic Steatohepatitis,NASH)是NAFLD进展而来的严重慢性肝脏疾病,流行病学数据显示,15%~25%的NAFLD患者最终会发展为NASH。 全球平均每3个人中就...
非酒精性脂肪性肝病(Nonalcoholic Fatty Liver Disease,NAFLD)是一种与胰岛素抵抗和遗传易感密切相关的代谢应激性肝脏损伤,疾 病谱包括非酒精性肝脂肪变(NAFL)、非酒精性脂肪性肝炎(NASH)及NASH相关肝硬化和肝细胞癌。 NASH表现为5%以上的肝细胞脂 肪变合并小叶内炎症和肝细胞气球样变性,大约有15%~25%的NAFLD会...
1. NAFLD:非酒精性脂肪性肝病(Non Alcoholic Fatty Liver Disease) | 非酒精性脂肪肝(Nonalcoholic Fatty Liver Disease) | 脂肪 … www.showxiu.com|基于4个网页 2. 非酒精性脂肪肝 NAFLD:非酒精性脂肪肝(Non Alcoholic Fatty Liver Disease)。美国有研究发现,AIDS患者在HAART治疗后易出现高TG和高… ...
A. 非酒精性脂肪性肝炎(non-alcoholic steatohepatitis, NASH) B. 脂肪肝肾综合征(fatty liver kidney syndrome) C. 肝纤维化(liver fibrosis) D. 肝硬化(liver cirrhosis) 相关知识点: 试题来源: 解析 B. 脂肪肝肾综合征(fatty liver kidney syndrome) ...
non-alcoholic fatty liver disease 青云英语翻译 请在下面的文本框内输入文字,然后点击开始翻译按钮进行翻译,如果您看不到结果,请重新翻译! 翻译结果1翻译结果2翻译结果3翻译结果4翻译结果5 翻译结果1复制译文编辑译文朗读译文返回顶部 非酒精性脂肪肝病 翻译结果2复制译文编辑译文朗读译文返回顶部...
NAFLD是指除外酒精和其他明确的损肝因素所致的肝细胞内脂肪过度沉积为主要特征的临床病理综合征,与胰岛素抵抗和遗传易感性密切相关的获得性代谢应激性肝损伤。包括单纯性脂肪肝(SFL)、非酒精性脂肪性肝炎(NASH)及其相关肝硬化。非酒精性脂肪性肝病除可直接导致失代偿期肝硬化、肝细胞癌和移植肝复发外,还可影响其他慢性...
Fatty Liver Disease Types There are two main types of FLD: 1. Metabolic dysfunction-associated steatotic liver disease (MASLD) This type used to be called nonalcoholic fatty liver disease (NAFLD). It is very common in the U.S., affecting 1 in 3 adults. Researchers aren't exactly sure wh...
Fatty Liver Disease Types There are two main types of FLD: 1. Metabolic dysfunction-associated steatotic liver disease (MASLD) This type used to be called nonalcoholic fatty liver disease (NAFLD). It is very common in the U.S., affecting 1 in 3 adults. Researchers aren't exactly sure wh...
NAFLD (Non AlcoholicFatty Liver Disease). tipschina.gov.cn tipschina.gov.cn 这些疾病又导致了非酒精性脂肪性肝病(NAFLD)等许多并发症的增加。 tipschina.gov.cn tipschina.gov.cn [...] procedures for injection of their respective existingnonalcoholicbeverage operations ...
Non-alcoholic fatty liver disease (NAFLD) has emerged pandemically across the globe and particularly affects patients with obesity and type 2 diabetes. NAFLD is a complex systemic disease that is characterised by hepatic lipid accumulation, lipotoxicity, insulin resistance, gut dysbiosis and inflammation...